We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current MSB market cap is 1.09B. The company's latest EPS is USD -0.0807 and P/E is -13.26.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 16M | 33.07M | 26.19M | 17.02M | 19.85M |
| Operating Income | -87.89M | -74.81M | -90.41M | -73.76M | -60.44M |
| Net Income | -89.8M | -77.94M | -98.81M | -91.35M | -81.89M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 652.12M | 733.6M | 744.72M | 662.14M | 669.42M |
| Total Liabilities | 171.06M | 184.28M | 163.32M | 165.1M | 167.58M |
| Total Equity | 481.05M | 549.33M | 581.4M | 497.04M | 501.84M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -57.79M | -56.37M | -106.68M | -65.78M | -63.27M |
| Investing | -1M | -3.27M | -1.65M | -232k | -194k |
| Financing | 71.61M | 137.04M | 114.47M | -9.87M | 74.5M |
| Market Cap | 1.09B |
| Price to Earnings Ratio | -13.26 |
| Price to Sales Ratio | 54.59 |
| Price to Cash Ratio | 15.24 |
| Price to Book Ratio | 2.16 |
| Dividend Yield | - |
| Shares Outstanding | 1.02B |
| Average Volume (1 week) | 15.77M |
| Average Volume (1 Month) | 11.9M |
| 52 Week Change | 7.54% |
| 52 Week High | 1.425 |
| 52 Week Low | 0.255 |
| Spread (Intraday) | 0.01 (0.47%) |
| Company Name | Mesoblast Limited |
| Address |
level 38 melbourne, victoria 3000 |
| Website | https://www.mesoblast.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
